BWA
NVCR icon

Burt Wealth Advisors’s NovoCure NVCR Stock Holding History

Burt Wealth Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-110
Closed -$19K – 268
2020
Q4 		$19K Hold
110
– – 0.01% 244
2020
Q3 		$12K Hold
110
– – ﹤0.01% 274
2020
Q2 		$7K Hold
110
– – ﹤0.01% 282
2020
Q1 		$7K Hold
110
– – ﹤0.01% 289
2019
Q4 		$9K Hold
110
– – ﹤0.01% 276
2019
Q3 		$8K Hold
110
– – ﹤0.01% 281
2019
Q2 		$7K Buy
+110
New +$5.57K ﹤0.01% 287

Other funds holding NVCR

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Burt Wealth Advisors's NVCR Position: Q1 2021 in Review

Burt Wealth Advisors sold out of NovoCure (NVCR) in Q1 2021, closing a stake of 110 shares — an estimated $19K sold.

Burt Wealth Advisors first reported a position in NVCR in Q2 2019 and held it in 7 quarters. The position peaked at $19K in Q4 2020. 327 funds tracked by Wall St. Rank hold NVCR as of Q1 2021.

  • Burt Wealth Advisors reported no remaining NovoCure position as of Q1 2021 after selling out during the quarter.
  • Burt Wealth Advisors sold 110 NovoCure shares in Q1 2021, an estimated $19K.
  • Burt Wealth Advisors first reported a position in NovoCure in Q2 2019 and held it in 7 quarters.
  • Burt Wealth Advisors's NovoCure position peaked at $19K in Q4 2020.
  • 327 funds tracked by Wall St. Rank held NovoCure as of Q1 2021.

Based on Burt Wealth Advisors's 13F filing for Q1 2021, filed 15 Apr 2021.